Compare Research Peptides

Select 2 peptides to compare benefits, dosage, administration routes, mechanisms, and side effect profiles side by side.

Peptide 1

Peptide 2

	Triptorelin Trelstar Sign up to track	Myostatin GDF-8 Sign up to track
Evidence Grade	AEvidenceGrade ALarge human randomised controlled trials or FDA/major-authority approved	DEvidenceGrade DTheoretical or in-vitro only; no meaningful independent human evidence
Regulatory	FDA ApprovedFDA ApprovedApproved by the US Food and Drug Administration for at least one indication	Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only
Category	Specialized Peptides	Specialized Peptides
Key Benefits	•Prostate cancer treatment •Fertility treatment •Endometriosis management •Precocious puberty treatment	•Muscle growth regulation research •Understanding muscle physiology
Dosage	0.1 mg mg	N/A mcg
Frequency	Single dose or monthly	N/A
Administration	Subcutaneous	Subcutaneous
Mechanism	A GnRH (gonadotropin-releasing hormone) agonist used medically for prostate cancer, endometriosis, precocious puberty, and fertility treatments. Causes initial hormone surge followed by suppression.	Growth Differentiation Factor 8 (GDF-8), a naturally occurring protein that limits muscle growth. Research focuses on its inhibition for muscle wasting diseases and performance applications.
Side Effects / Risks	•Hot flashes •Decreased libido •Headache	Not specified
Research Status	Extensive Clinical Data	Moderate Clinical Data